Human rs75776403 polymorphism links differential phenotypic and clinical outcomes to a CLEC18A p.T151M-driven multiomics

J Biomed Sci. 2022 Jun 18;29(1):43. doi: 10.1186/s12929-022-00822-1.

Abstract

Background: Human traits, diseases susceptibility, and clinical outcomes vary hugely among individuals. Despite a fundamental understanding of genetic (or environmental) contributions, the detailed mechanisms of how genetic variation impacts molecular or cellular behaviours of a gene, and subsequently leads to such variability remain poorly understood.

Methods: Here, in addition to phenome-wide correlations, we leveraged multiomics to exploit mechanistic links, from genetic polymorphism to protein structural or functional changes and a cross-omics perturbation landscape of a germline variant.

Results: We identified a missense cis-acting expression quantitative trait locus in CLEC18A (rs75776403) in which the altered residue (T151→M151) disrupts the lipid-binding ability of the protein domain. The altered allele carriage led to a metabolic and proliferative shift, as well as immune deactivation, therefore determines human anthropometrics (body height), kidney, and hematological traits.

Conclusions: Collectively, we uncovered genetic pleiotropy in human complex traits and diseases via CLEC18A rs75776403-regulated pathways.

Keywords: Body height; CLEC18A; CLEC18A p.T151M; Phosphatidic acid (PA); Phosphatidylserine (PS); Thyroid hormone; rs75776403.

MeSH terms

  • Alleles
  • Genetic Pleiotropy*
  • Genome-Wide Association Study
  • Humans
  • Lectins, C-Type / genetics
  • Phenotype
  • Polymorphism, Genetic*
  • Polymorphism, Single Nucleotide

Substances

  • CLEC18A protein, human
  • Lectins, C-Type